Stocktoria

RIGEL PHARMACEUTICALS INC RIGL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2000-11-29 · LEI

RIGEL PHARMACEUTICALS INC statistics & valuation

Market cap$715.8M
P / E2.0×
P / S2.4×
P / B1.8×
Net margin124.7%
Return on equity93.8%
Net debt$11.9M
Net debt / EBITDA0.1×
Enterprise value USD$727.8M
EV / EBITDA5.7×
Earnings yield EBIT/EV17.2%
Return on capital30.3%
Graham number +127.9%$95.43

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($95.43); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-112.80% -27.40% -12.00% -48.70% -21.50% 9.80% 124.70% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-342.20% -1775.60% -163.30% -116.50% -26.70% -8.40% -46.20% -17.50% 13.50% 42.60% 2016201720182019202020212022202320242025
Return on equity (%)
-124.30% -87.40% -59.00% 531.80% 93.80% 2016201720182019202020212022202320242025
Shares outstanding
99.3M 146.8M 167.2M 168.0M 169.3M 171.6M 173.4M 17.5M 17.7M 18.8M 2016201720182019202020212022202320242025
Net debt ($)
-$12.5M -$10.4M $1.1M $15.5M $27.2M $3.3M $11.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-45.30% -26.90% -10.70% -43.60% -21.40% 10.70% 71.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-376.30% -1733.30% -134.70% -72.50% -49.20% 3.50% -61.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.19× 0.59× 0.66× 18.25× 0.13× 2016201720182019202020212022202320242025
EPS ($)
-$0.40 -$0.18 -$0.11 -$3.44 -$1.44 $0.99 $19.48 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin42.6%13.5%-17.5%-46.2%-8.4%-26.7%-116.5%-163.3%-1775.6%-342.2%
Net margin124.7%9.8%-21.5%-48.7%-12.0%-27.4%-112.8%———
FCF margin———-61.7%3.5%-49.2%-72.5%-134.7%-1733.3%-376.3%
Return on assets71.5%10.7%-21.4%-43.6%-10.7%-26.9%-45.3%———
Return on equity93.8%531.8%87.6%430.2%-59.0%-87.4%-124.3%———
Debt / equity0.13×18.25×-2.09×-2.94×0.66×0.59×0.19×———
Current ratio2.422.131.861.782.432.182.044.946.403.37

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.